The First-Ever Government Negotiation Process for Drugs Has Finished, But the Politics Are Ongoing

A Health Affairs Forefront post discusses the potential savings from the first-ever Medicare drug price negotiations for both government and beneficiaries. The authors also explore how politicians’ views on the issue could influence future elections and the development of government drug price negotiations.